Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Nizatidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH2 known ✓ | P25021 | 2/20 | 0.53 |
| ▸ | ACHE | P22303 | 4/20 | 0.88 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.53 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.53 |
| ▸ | ATP4A | P20648 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | ATP4B | P51164 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nizatidine SCHEMBL769 | 0.94 | ACHE (1.00) | ACHEHRH2MEN1SLC22A1ABCB11 | |
| Nizatidine SCHEMBL770 | 0.94 | ACHE (1.00) | ACHEHRH2MEN1SLC22A1ABCB11 | |
| Nizatidine SCHEMBL13575816 | 0.94 | ACHE (1.00) | ACHEHRH2MEN1SLC22A1ABCB11 | |
| Nizatidine SCHEMBL9241933 | 0.94 | ACHE (1.00) | ACHEHRH2MEN1SLC22A1ABCB11 | |
| Nizatidine SCHEMBL28723397 | 0.93 | ACHE (0.98) | ACHEHRH2MEN1SLC22A1ABCB11 | |
| Nizatidine SCHEMBL5041217 | 0.93 | ACHE (0.98) | ACHEHRH2MEN1SLC22A1ABCB11 | |
| Nizatidine SCHEMBL6239553 | 0.92 | ACHE (0.96) | ACHEHRH2MEN1SLC22A1ABCB11 | |
| Nizatidine SCHEMBL28102651 | 0.91 | ACHE (0.94) | ACHEHRH2MEN1SLC22A1ABCB11 | |
| Nizatidine SCHEMBL9369533 | 0.89 | ACHE (0.80) | ACHEHRH2MEN1SLC22A1ABCB11 | |
| Nizatidine SCHEMBL9369530 | 0.89 | ACHE (0.80) | ACHEHRH2MEN1SLC22A1ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10227598-B2 | Sugarcane bacilliform viral (SCBV) enhancer and its use in plant functional genomics | DOW AGROSCIENCES LLC (US) | 2019-03-12 | — | — | US | disclosed |
| EP-3362071-A1 | CRYSTALLIZATION METHOD AND BIOAVAILABILITY | Grünenthal GmbH (DE) | 2018-08-22 | — | — | EP | disclosed |
| EP-2611925-B1 | SUGARCANE BACILLIFORM VIRAL (SCBV) ENHANCER AND ITS USE IN PLANT FUNCTIONAL GENOMICS | DOW AGROSCIENCES LLC (US) | 2017-11-29 | — | — | EP | disclosed |
| WO-2017049294-A1 | CRYSTALLIZATION METHOD AND BIOAVAILABILITY | THAR PHARMACEUTICALS, INC. (US) | 2017-03-23 | — | — | WO | disclosed |
| US-20160251733-A1 | SUGARCANE BACILLIFORM VIRAL (SCBV) ENHANCER AND ITS USE IN PLANT FUNCTIONAL GENOMICS | DOW AGROSCIENCES LLC (US) | 2016-09-01 | — | — | US | disclosed |
| CN-103201389-B | Sugarcane bacilliform virus (SCBV) enhanser and the purposes in plant functional genomics thereof | DOW AGROSCIENCES LLC (US) | 2015-09-23 | — | — | CN | disclosed |
| US-20140289899-A1 | SUGARCANE BACILLIFORM VIRAL (SCBV) ENHANCER AND ITS USE IN PLANT FUNCTIONAL GENOMICS | DOW AGROSCIENCES LLC | 2014-09-25 | — | — | US | disclosed |
| US-8785612-B2 | Sugarcane bacilliform viral (SCBV) enhancer and its use in plant functional genomics | AGRIGENETICS, INC. (US) | 2014-07-22 | — | — | US | disclosed |
| EP-2611925-A1 | SUGARCANE BACILLIFORM VIRAL (SCBV) ENHANCER AND ITS USE IN PLANT FUNCTIONAL GENOMICS | Dow AgroSciences LLC (US) | 2013-07-10 | — | — | EP | disclosed |
| CN-103201389-A | Sugarcane bacilliform viral (SCBV) enhancer and its use in plant functional genomics | DOW AGROSCIENCES LLC | 2013-07-10 | — | — | CN | disclosed |
| WO-2011097269-A9 | CRYSTALLIZATION METHOD AND BIOAVAILABILITY | THAR PHARMACEUTICALS, INC. (US) | 2012-12-27 | — | — | WO | disclosed |
| EP-2531200-A1 | CRYSTALLIZATION METHOD AND BIOAVAILABILITY | Thar Pharmaceuticals, Inc. (US) | 2012-12-12 | — | — | EP | disclosed |
| WO-2012030711-A1 | SUGARCANE BACILLIFORM VIRAL (SCBV) ENHANCER AND ITS USE IN PLANT FUNCTIONAL GENOMICS | AGRIGENETICS, INC. (US) | 2012-03-08 | — | — | WO | disclosed |
| US-20120054908-A1 | SUGARCANE BACILLIFORM VIRAL (SCBV) ENHANCER AND ITS USE IN PLANT FUNCTIONAL GENOMICS | AGRIGENETICS, INC. | 2012-03-01 | — | — | US | disclosed |
| WO-2011097269-A1 | CRYSTALLIZATION METHOD AND BIOAVAILABILITY | THAR PHARMACEUTICALS, INC. (US) | 2011-08-11 | — | — | WO | disclosed |
| US-7667100-B2 | Nucleic acid compositions conferring herbicide resistance | DOW AGROSCIENCES LLC (US) | 2010-02-23 | — | — | US | disclosed |
| US-20050066392-A1 | Nucleic acid compositions conferring herbicide resistance | DOW AGROSCIENCES LLC | 2005-03-24 | — | — | US | disclosed |